About

Alan Askari is a leading researcher in minimally invasive and robotic-assisted surgery, with a focused expertise in colorectal cancer and hepatobiliary procedures. His work critically evaluates the real-world benefits and costs of robotic surgery compared to traditional laparoscopic and open approaches. Askari’s most cited study, a 2022 comparison of robotic versus laparoscopic left-sided colorectal cancer resections (23 citations), provides pivotal data on surgical outcomes outside formal enhanced recovery programs, challenging assumptions about robotic superiority. He further extended this analysis to emergency general surgery with a 2024 systematic review (13 citations), addressing a critical gap in evidence for acute care settings. Notably, his 2024 comparative cost analysis of liver resections (4 citations) at a UK university hospital offers rare financial insights, weighing operative expenses against clinical benefits. By systematically quantifying trade-offs in safety, efficacy, and cost, Askari’s research equips surgeons and policymakers with evidence to guide technology adoption. His work is essential for students and clinicians navigating the evolving landscape of robotic surgery, balancing innovation with pragmatic, patient-centered outcomes.

Research Focus

Key Achievements

3
H-Index
3
Papers
40
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of robotic vs laparoscopic left-sided colorectal cancer resections
23 citations · 2022
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust, Luton and Dunstable University Hospital NHS Foundation Trust

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago